Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250605838138/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522374364/en/Immunome-to-Present-at-Upcoming-Investor-Conferences
12 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250512278188/en/Immunome-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update
02 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250502947768/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
04 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250404736622/en/Immunome-to-Present-at-the-24th-Annual-Needham-Virtual-Healthcare-Conference
03 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250403273378/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
ABOUT THIS PAGE